Literature DB >> 29624114

Ultrastructural analysis of human umbilical cord derived MSCs at undifferentiated stage and during osteogenic and adipogenic differentiation.

Serbay Ozkan1, Basak Isildar1, Mahmut Oncul2, Zafer Baslar3, Semih Kaleli2, Meral Koyuturk1.   

Abstract

Mesenchymal stem cells (MSCs) are considered as an important tool for regenerative medicine and experimental treatments. Unveiling the ultrastructural changes during the differentiation of MSCs might help us to understand the nature of the process and to develop novel therapeutic approaches. For this purpose, human umbilical cord (hUC) was chosen as MSC source. In the first place, MSCs were isolated from sub-amniotic, intervascular and perivascular areas of hUC by enzymatic and tissue explant method to determine the most favorable region of hUC and technique for further processing. Therefore, microscopic and growth kinetics analyses showed that there was no clear difference in the morphologies and proliferation rates among the hUC-MSC groups. Flow cytometric analysis showed that CD44 and CD90 MSC markers were highly expressed, while CD34 and CD45 hematopoietic stem cells markers were expressed at low degree. Because our preliminary results showed that there was no conspicuous superiority among the hUC-MSCs groups, whole UC was utilized as a source, and tissue explant method was applied to isolate MSCs for further differentiation analysis. At the 1st and 3rd week of osteogenic and adipogenic differentiation, ultrastructural analysis showed an increase in the number of secondary lysosomes in comparison with the undifferentiated status. Increase in the mitochondrial content was also detected at the 1st week of adipogenic differentiation. Consequently, ultrastructural changes including increase in the number of mitochondria and secondary lysosomes during the adipogenic and osteogenic differentiation could be attributed to the switch in energy metabolism of the MSCs and increment in the lysosomal activity respectively.

Entities:  

Keywords:  Differentiation; lysosomal activity; mesenchymal stem cells; transmission electron microscopy; umbilical cord

Mesh:

Year:  2018        PMID: 29624114     DOI: 10.1080/01913123.2018.1453905

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  2 in total

1.  Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial.

Authors:  Neslihan Sinim Kahraman; Ayse Oner
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

2.  Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model.

Authors:  Serbay Ozkan; Basak Isildar; Merve Ercin; Selda Gezginci-Oktayoglu; Dildar Konukoglu; Neşet Neşetoğlu; Mahmut Oncul; Meral Koyuturk
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.